150
Participants
Start Date
October 19, 2023
Primary Completion Date
June 6, 2025
Study Completion Date
July 31, 2026
IBI363
IBI363 monotherapy
RECRUITING
Beijing Cancer Hospital, Beijing
RECRUITING
Peking University Cancer Hospital & Institute, Beijing, China,, Beijing
RECRUITING
Jilin Cancer Hospital, Changchun
RECRUITING
The first hospital of Jilin University, Changchun
RECRUITING
Nanjing Drum Tower Hospital, Nanjing
RECRUITING
Qilu Hospital of Shandong university, Jinan
RECRUITING
The first affiliated hospital of Nanchang university, Nanchang
RECRUITING
Fujian Cancer Hospital, Fuzhou
RECRUITING
Hunan Cancer Hospital, Changsha
RECRUITING
The Third people's hospital of Zhengzhou, Zhengzhou
RECRUITING
Yunan Cancer Hospital, Kunming
RECRUITING
Shanxi Bethune Hospital, Taiyuan
Innovent Biologics (Suzhou) Co. Ltd.
INDUSTRY